Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

 

Raised: $244,520.00
Goal: $500,000.00

 

Donate Now

 

Educational Materials

  publications

Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.

Order Free Materials Today

Parkinson's HelpLine

 

Learn More


Science News

Pfizer to Discontinue Sumanirole Development Program

Pfizer Inc said today that it is ceasing the clinical development of sumanirole, a compound under investigation for the treatment of Parkinson's disease and Restless Leg Syndrome. The decision is based on results of recent studies that failed to sufficiently distinguish sumanirole from currently available therapies. While the compound may still prove effective in these conditions, it did not meet Pfizer's criteria for continued development. Today's statement is an update to the company's second quarter business performance conference call with financial analysts and media on July 21, 2004.

Source Date: Jul 21 2004
Source Publication: Pfizer Inc